Nuveen Asset Management, LLC Mersana Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 123,339 shares of MRSN stock, worth $229,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares

123,339

Previous 65,881 87.21%

Holding current value

$229,410

Previous $152,000 263.16%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.16 - $5.94 $124,109 - $341,300	57,458 Added 87.21%	123,339 $552,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $1.25 Million - $4.6 Million	-1,175,710 Reduced 94.69%	65,881 $83,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $320 - $993	104 Added 0.01%	1,241,591 $4.08 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $48,320 - $84,801	12,080 Added 0.98%	1,241,487 $5.1 Million
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $224,384 - $312,152	-39,714 Reduced 3.13%	1,229,407 $7.2 Million

Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $3.83 Million - $6.62 Million	827,287 Added 187.24%	1,269,121 $8.58 Million
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $404,370 - $711,920	142,384 Added 47.55%	441,834 $2.04 Million
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $24,283 - $43,048	6,493 Added 2.22%	299,450 $1.2 Million
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $91,894 - $165,342	16,769 Added 6.07%	292,957 $1.82 Million
Q3 2021 Nov 12, 2021	BUY	$8.56 - $14.47 $139,014 - $234,992	16,240 Added 6.25%	276,188 $2.6 Million
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $232,652 - $316,568	17,519 Added 7.23%	259,948 $3.53 Million
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $2.35 Million - $4.07 Million	-153,614 Reduced 38.79%	242,429 $3.92 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $452,271 - $740,984	26,857 Added 7.27%	396,043 $10.5 Million
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $2.17 Million - $3.44 Million	-133,765 Reduced 26.6%	369,186 $6.87 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $1.62 Million - $7.25 Million	309,668 Added 160.21%	502,951 $11.8 Million
Q1 2020 May 14, 2020	BUY	$4.41 - $9.28 $239,030 - $502,994	54,202 Added 38.97%	193,283 $1.13 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $45,344 - $210,460	31,272 Added 29.01%	139,081 $797,000
Q2 2019 Aug 15, 2019	BUY	$3.84 - $6.4 $413,986 - $689,977	107,809 New	107,809 $437,000

Others Institutions Holding MRSN

# of Institutions

128

Shares Held

118M

Call Options Held

68.1K

Put Options Held

140K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $181M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Mersana Therapeutics, Inc. Transaction History